谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

MDS-420: Sabatolimab Plus Hypomethylating Agents (hmas) in Patients with High-/Very High-risk Myelodysplastic Syndrome (Hr/vhr-Mds) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study

Guillermo Garcia-Manero,Andrew H. Wei,Kimmo Porkka,Steve Knapper,Elie Traer,Sebastian Scholl,Norbert Vey,Martin Wermke,Jeroen Janssen,Rupa Narayan,Sun Loo,Natalia Tovar,Mika Kontro,Oliver Ottmann,Purushotham Naidu,Elena Orlando,Nidhi Patei,Jessica Makofske,Fei Ma,Na Zhang

Clinical Lymphoma Myeloma & Leukemia（2021）

引用 3|浏览5
关键词
MDS,acute myeloid leukemia,clinical trial,immunotherapy,myelodysplasia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要